J.M. Tourani

1.3k citations
34 papers · 807 indexed · h-index 15
Topics
Lung Cancer Treatments and Mutations (6 papers)Lung Cancer Research Studies (5 papers)Renal cell carcinoma treatment (4 papers)

In The Last Decade

J.M. Tourani

34 papers receiving 783 citations

Peers

J.M. Tourani
Comparison fields: 5 of 76
  • Oncology 481
  • Immunology 201
  • Pulmonary and Respiratory Medicine 183
  • Molecular Biology 152
  • Pathology and Forensic Medicine 97
Replace Nicoletta Pella with:
Nicoletta Pella Italy
Rafael Quadri Switzerland
W. M. Gallmeier Germany
G. D. Cummings United States
R. L. Priore United States
B.M. Dale Australia
Tzahi Neuman Israel
Samy Louafi France
Karen Antman United States
Y Carcassonne France
J.M. Tourani relative to Nicoletta Pella Italy Nicoletta Pella's profile →
Citations per field
00.5×1.5×
Nicoletta Pella · 1×
Citations per year

Countries citing papers authored by J.M. Tourani

Since Specialization
Citations

This map shows the geographic impact of J.M. Tourani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Tourani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Tourani more than expected).

Fields of papers citing papers by J.M. Tourani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Tourani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Tourani. The network helps show where J.M. Tourani may publish in the future.

Co-authorship network of co-authors of J.M. Tourani

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Tourani. A scholar is included among the top collaborators of J.M. Tourani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Tourani. J.M. Tourani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 46
2 3
3 23
4 3
5 10
6 12
7 32
8 32
9 43
10 28
11
[Treatment of advanced kidney cancer using recombinant erythropoietin].
8
12 28
13 20
14 16
15 116
16 6
17 108
18 39
19 30
20 3

About J.M. Tourani

J.M. Tourani is a scholar working on Oncology, Virology and Otorhinolaryngology, having authored 34 papers that have together received 807 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Oncology (481 citations), Virology (66 citations) and Immunology (201 citations). J.M. Tourani has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include J Andrieu, Dominique Israël‐Biet, P Even, H Sors, François Labrousse, D. Khayat, E. Vuillemin, E Antoine, L Thill and Olivier Rixe. Their work appears in journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026